Joseph Patti
Works at
President & ceo, 25 Aug 2025, reporter.nih.gov
Grants and prizes
National Heart, Lung, and Blood Institute
R44, Advanced Pre-clinical development of Nox4 inhibitors for Pulmonary Fibrosis, R44HL172475, 2024–2027, 25 Aug 2025, reporter.nih.gov